Statement by Israeli International Law Scholars Concerning Israel’s New “Death Penalty for Terrorists” Law

Israel’s Knesset enacted a new “Death Penalty for Terrorists” law that makes hanging the default sentence in military courts for Palestinians convicted of deadly attacks, converts an optional capital sentence in the West Bank into a default one, removes the military commander’s power to commute, and limits the Prime Minister to requesting a suspension of execution for up to 180 days. A group of Israeli international law scholars state the law breaches the ICCPR and the Fourth Geneva Convention, discriminates against Palestinians (potentially amounting to apartheid), and have called on the Supreme Court to enjoin and strike down the law while urging the Attorney General not to defend it.

Analysis

The immediate market channel is political/legal risk translating into sovereign-credit and equity repricing rather than a pure operational shock. If petitions proceed to a full hearing and international diplomatic pushback follows, we think Israeli sovereign spreads can widen 75–150bp over 3–6 months and MSCI Israel equity exposure (ETF proxy EIS) could underperform global peers by 8–15% in a base case; a sustained legal-political stalemate raises the tail to ~25% downside.

Second-order winners and losers bifurcate along two axes: (1) firms with direct operational or reputational exposure inside the occupied territories are vulnerable to ESG-driven divestment and litigation flows, creating measurable idiosyncratic downside; (2) traditional defense integrators that sell into Israeli rearmament cycles and allied bilateral aid channels (e.g., US primes) stand to gain modest order upside and margin tailwinds. Expect reallocation within portfolios: active managers will trim Israel/EM allocations and rotate into perceived safe-haven secular beneficiaries.

Timing and catalysts are clear and stagable: days — court injunction filings and preliminary rulings that drive intraday volatility; weeks–months — rulings, international statements, potential sanctions discussions, and ratings agency commentary; 6–24 months — legislative or electoral reversals that would either normalize risk premia or embed a new political-normal. The single biggest risk to the down case is a rapid judicial strike-down or decisive allied diplomatic backstop, which could erase >50% of the initial spread widening within 1–3 months.

Given the asymmetric legal tail (litigation and reputational risk) and its volatility, the efficient response is hedged, time-limited exposure reduction rather than binary long-or-short bets; focus on instruments that isolate Israel-specific political risk while keeping global cyclical exposure intact.

Key Decisions for Investors

• Short MSCI Israel ETF (EIS) vs long S&P 500 (SPY) — target a 3–9 month horizon. Base case: EIS -10% vs SPY flat; allocate 1–2% NAV to the pair trade. Add EIS 3–6 month puts as insurance (cost ~1–3% premium) to cap downside.
• Buy US Treasuries (TLT) and Gold (GLD) as immediate hedges for flight-to-quality over 0–3 months. Position size: 2–4% NAV split (TLT 60% / GLD 40%); expected protective payoff asymmetry >2:1 if volatility spikes.
• Long US defense primes (Lockheed LMT or RTX) vs short EIS — 6–12 month trade to capture potential procurement upside while hedging Israel-specific political risk. Target 6–12% upside on the long leg; use 10–20% notional hedge on the short leg.
• Purchase discrete tail protection on Israeli credit via sovereign CDS or, if unavailable, long-dated put options on Israeli bank ADRs or EIS (9–12 month). Treat premia as insurance; aim to limit downside to 20–25% in extreme sanctions/litigation scenario.
• Reduce active Israel/EM country exposure now by 20–40% for portfolios with limited hedges; redeploy into regional peers (EU/US tech) where idiosyncratic legal risk is lower. Revisit after court rulings or diplomatic clarifications within 3 months.